Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

G, Frasci; V, Lorusso; N, Panza; P, Comella; G, Nicolella; A, Bianco; Cataldis G, De; A, Iannelli; D, Bilancia; M, Belli; B, Massidda; F, Piantedosi; G, Comella; Lena M, De

doi:10.1200/jco.2000.18.13.2529

Public

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

Shared by NobleBlocks on Jul 1, 2000 • 12:00 AM UTC

Authors:

Frasci G

Lorusso V

Panza N

Abstract

<h4>Purpose</h4>To evaluate whether the addition of gemcitabine (G) to vinorelbine (V) improves survival and quality of life (QoL) among elderly patients with advanced non-small-cell lung cancer (NSCLC).<h4>Patients and methods</h4>Patients with NSCLC aged >/= 70 years with advanced disease were ran...

Discussions